Targeted molecular imaging of VEGF receptors overexpressed in ischemic microvasculature using chitosan-DC101 conjugates

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 4, 2010, Pages 1510-1517

  Lee, Chang Moon ^a   Kim, Eun Mi ^a   Cheong, Su Jin ^a   Kim, Dong Wook ^a   Lim, Seok Tae ^a   Sohn, Myung Hee ^a   Jeong, Hwan Jeong ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Chitosan; DC101; Ischemia; Molecular imaging; VEGF receptor

Indexed keywords

CELL-BINDING; DC101; FEMORAL ARTERY OCCLUSION; HIND LIMBS; IN-VITRO; MICRO-VASCULATURE; MOLECULAR IMAGING; MOUSE MODELS; OPTICAL IMAGING; SCINTIGRAPHIC IMAGING; SEMI-QUANTITATIVE ANALYSIS; TARGETED IMAGING; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR-2; WESTERN BLOTTING;

BINDING ENERGY; CHITIN; CHITOSAN; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION; MUSCLE;

MULTILAYERS;

CHELATING AGENT; CHITOSAN PLUS MONOCLONAL ANTIBODY DC101 CY5.5; CHITOSAN PLUS MONOCLONAL ANTIBODY DC101 TECHNETIUM 99M; FLUORESCEIN ISOTHIOCYANATE; TRACER; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG SYNTHESIS; ENDOTHELIUM CELL; FEMALE; FEMORAL ARTERY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIMB ISCHEMIA; MICROVASCULATURE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UMBILICAL VEIN; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; CARBOCYANINES; CELLS, CULTURED; CHITOSAN; FEMALE; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, INBRED BALB C; MICROVESSELS; MOLECULAR IMAGING; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; RADIONUCLIDE IMAGING; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TECHNETIUM;

EID: 77349126916     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32470     Document Type: Article

References (18)

1. Rissanen TT, Vajanto I, Hiltnen MO, Rutanen J, Kettunen MI, Niemi M, Leppänen P, Turnen MP, Markkanen JE, Arve K, Alhava E, Kauppinen RA, Ylä-Herttuala S. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 2002;160:1393-1403.
2. Lu E, Wagner WR, Schellenberger U, Abraham JA, Klibanov AL, Woulfe SR, Csikari MM, Fischer D, Scheriner GF, Brandenrger GH, Villanueva FS. Targeted in vivo labeling of receptors for vascular endothelial growth factor approach to identification of ischemic tissue. Circulation 2003;8:97-103.
3. 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 2008;19:915-922.
4. Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres. Int J Pharm 2008;359:205-210.
5. Jiang HL, Kwon JT, Kim YK, Kim EM, Arote R, Jeong HJ, Nah JW, Choi YJ, Akaike T, Cho MH, Cho CS. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene Ther 2007;14:1389-1398.
6. 99mTc-Transferrin conjugate for detection of inflamed site. J Drug Taret 2007;15:595-602.
7. Prewett M, Li JHY, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 1999;59:5209-5218.
8. Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, Hallett W, Tsou HR, Upeslacis J, Shochat D, Mountain A, Flowers DA, Bernstein I. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug Chem 2002;13:47-58.
9. Lee KH, Jung KH, Song SH, Kim DH, Lee BC, Sung HJ, Han YM, Choe YS, Chi DY, Kim BT. Radiolabeled RGD uptake and av intergrin expression is enhanced in ischemic murine hindlimbs. J Nucl Med 2005;46:472-748.
10. Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CPD. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 2007;214:537-544.
11. Akizawa H, Uehara T, Arano Y. Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins. Adv Drug Deliv Rev 2008;60:1319-1328.
12. 111In- diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Res 1995;55:5714s-5720s.
13. 99mTc-galactosylated chitosan: Conjugation, targeting, biodistribution. J Nucl Med 2005;46:141-145.
14. 99mTc galactosylated chitosan. Nucl Med Biol 2006;33:529-534.
15. Jacobi J, Porst M, Cordasic N, Namer B, Schmieder RE, Eckardt KU, Hilgers KF. Subtotal nephrectomy impairs ischemiainduced angiogenesis and hindlimb re-perfusion in rats. Kidney Int 2006;69:2013-2021.
16. Ran S, Huang X, Downes A, Thorpe PE. Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy. Neoplasia 2003;5:297-307.
17. Brogi E, Schatteman G, Wu T. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996;97:469-476.
18. Chen W, Zhang F, Chen MB, Lineaweaver WC. Expression of vascular endothelial growth factor receptor-2 in the muscle flap with ischemic injury in rats. J Surg Res 2006;140:45-49.